Current FDA Requirements for Cleaning Validation
Since the GMP regulations are sometimes not specific, concrete regulatory guidance on implementation is very helpful. In a current Warning Letter, the FDA specifies their requirements for cleaning validation. What does the FDA require?
In the Warning Letter, the medicinal product manufacturer is criticized for not having written instructions for cleaning and for not having carried out a cleaning validation. In addition to a risk assessment regarding the cleaning in the past and its effects on the product quality, the FDA also requires a comprehensive plan with
- a cleaning validation strategy,
- procedures
- protocols
- timelines for the cleaning validation activities
Furthermore, the FDA still requires a cleaning validation program with special emphasis on "worst-case" scenarios. As a minimum, the following should be considered as worst-case scenarios
- Medicinal products with higher toxicities
- Medicinal products with higher medicinal potencies
- Medicinal products with lower solubility in their cleaning solvents
- Medicinal products with characteristics that make them difficult to clean
- Swabing locations for areas that are most difficult to clean
- Maximun hold times before cleaning.
Please see the FDA's Warning Letter issued to Syntec Pharma for more detailed information.
Related GMP News
16.07.2025Content of an Audit Trail / Must an Audit Trail be printable?
09.07.2025Drafts of EU GMP Guideline Annex 11, Annex 22 and Chapter 4 released for comment
07.05.2025Media Fill and Smoke Studies: FDA's Perspective
30.04.2025FDA expectations for Media Fills
30.04.2025Qualification of old installations in 2025
26.03.2025Correlation between Validation Master Plan and Validation Protocols